Picton Mahoney Asset Management’s Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share MTAL.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-51,314
Closed -$33K 1048
2021
Q4
$33K Buy
+51,314
New +$36.8K ﹤0.01% 873

Other funds holding MTAL.WS

Picton Mahoney Asset Management's MTAL.WS Position: Q1 2022 in Review

Picton Mahoney Asset Management sold out of Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share (MTAL.WS) in Q1 2022, closing a stake of 51,314 shares — an estimated $33K sold.

Picton Mahoney Asset Management first reported a position in MTAL.WS in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 29 funds tracked by Wall St. Rank hold MTAL.WS as of Q1 2022.

  • Picton Mahoney Asset Management reported no remaining Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 51,314 Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share shares in Q1 2022, an estimated $33K.
  • Picton Mahoney Asset Management first reported a position in Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share in Q4 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share position peaked at $33K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share as of Q1 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2022, filed 11 May 2022.